Concord Biotech Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Profit Before Tax	351.43	495.88	409.19	320.05
Net CashFlow-Operating Activity	263.78	244.52	265.47	246
Net Cash Used In Investing Activity	-142.28	-159.99	-154.61	-157.95
NetCash Used in Fin. Activity	-114.51	-98.77	-99.21	-85.22
Net Inc/Dec In Cash And Equivlnt	6.98	-14.24	11.64	2.83
Cash And Equivalnt Begin of Year	0.90	15.14	3.50	0.67
Cash And Equivalnt End Of Year	7.89	0.90	15.14	3.50

കൂടുതൽ »

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article